615 related articles for article (PubMed ID: 33187979)
21. A Potential Role of Interleukin 10 in COVID-19 Pathogenesis.
Lu L; Zhang H; Dauphars DJ; He YW
Trends Immunol; 2021 Jan; 42(1):3-5. PubMed ID: 33214057
[TBL] [Abstract][Full Text] [Related]
22. Tackling the COVID-19 "cytokine storm" with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs.
Gasparello J; Finotti A; Gambari R
Med Hypotheses; 2021 Jan; 146():110415. PubMed ID: 33422363
[TBL] [Abstract][Full Text] [Related]
23. The Mechanism behind Influenza Virus Cytokine Storm.
Gu Y; Zuo X; Zhang S; Ouyang Z; Jiang S; Wang F; Wang G
Viruses; 2021 Jul; 13(7):. PubMed ID: 34372568
[TBL] [Abstract][Full Text] [Related]
24. Could Perturbation of Gut Microbiota Possibly Exacerbate the Severity of COVID-19
Vignesh R; Swathirajan CR; Tun ZH; Rameshkumar MR; Solomon SS; Balakrishnan P
Front Immunol; 2020; 11():607734. PubMed ID: 33569053
[No Abstract] [Full Text] [Related]
25. Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19.
Lee JS; Park S; Jeong HW; Ahn JY; Choi SJ; Lee H; Choi B; Nam SK; Sa M; Kwon JS; Jeong SJ; Lee HK; Park SH; Park SH; Choi JY; Kim SH; Jung I; Shin EC
Sci Immunol; 2020 Jul; 5(49):. PubMed ID: 32651212
[TBL] [Abstract][Full Text] [Related]
26. Cytokine profile in plasma of severe COVID-19 does not differ from ARDS and sepsis.
Wilson JG; Simpson LJ; Ferreira AM; Rustagi A; Roque J; Asuni A; Ranganath T; Grant PM; Subramanian A; Rosenberg-Hasson Y; Maecker HT; Holmes SP; Levitt JE; Blish CA; Rogers AJ
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32706339
[TBL] [Abstract][Full Text] [Related]
27. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
Coperchini F; Chiovato L; Rotondi M
Front Immunol; 2021; 12():668507. PubMed ID: 33981314
[TBL] [Abstract][Full Text] [Related]
28. SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.
Beacon TH; Su RC; Lakowski TM; Delcuve GP; Davie JR
IUBMB Life; 2020 Nov; 72(11):2331-2354. PubMed ID: 32936531
[TBL] [Abstract][Full Text] [Related]
29. Single-Cell Sequencing of Peripheral Mononuclear Cells Reveals Distinct Immune Response Landscapes of COVID-19 and Influenza Patients.
Zhu L; Yang P; Zhao Y; Zhuang Z; Wang Z; Song R; Zhang J; Liu C; Gao Q; Xu Q; Wei X; Sun HX; Ye B; Wu Y; Zhang N; Lei G; Yu L; Yan J; Diao G; Meng F; Bai C; Mao P; Yu Y; Wang M; Yuan Y; Deng Q; Li Z; Huang Y; Hu G; Liu Y; Wang X; Xu Z; Liu P; Bi Y; Shi Y; Zhang S; Chen Z; Wang J; Xu X; Wu G; Wang FS; Gao GF; Liu L; Liu WJ
Immunity; 2020 Sep; 53(3):685-696.e3. PubMed ID: 32783921
[TBL] [Abstract][Full Text] [Related]
30. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
[TBL] [Abstract][Full Text] [Related]
31. Infusion of HLA-matched and static magnetic field-exposed allogenic lymphocytes treating lymphocytopenia and cytokine storm syndrome: A treatment proposal for COVID-19 patients.
Vergallo C
Electromagn Biol Med; 2021 Jan; 40(1):11-25. PubMed ID: 33073612
[TBL] [Abstract][Full Text] [Related]
32. Integrated single-cell analysis unveils diverging immune features of COVID-19, influenza, and other community-acquired pneumonia.
Schuurman AR; Reijnders TDY; Saris A; Ramirez Moral I; Schinkel M; de Brabander J; van Linge C; Vermeulen L; Scicluna BP; Wiersinga WJ; Vieira Braga FA; van der Poll T
Elife; 2021 Aug; 10():. PubMed ID: 34424199
[TBL] [Abstract][Full Text] [Related]
33. Targeting Cytokine Storm to Manage Patients with COVID-19: A Mini-Review.
Roshanravan N; Seif F; Ostadrahimi A; Pouraghaei M; Ghaffari S
Arch Med Res; 2020 Oct; 51(7):608-612. PubMed ID: 32682575
[TBL] [Abstract][Full Text] [Related]
34. A human circulating immune cell landscape in aging and COVID-19.
Zheng Y; Liu X; Le W; Xie L; Li H; Wen W; Wang S; Ma S; Huang Z; Ye J; Shi W; Ye Y; Liu Z; Song M; Zhang W; Han JJ; Belmonte JCI; Xiao C; Qu J; Wang H; Liu GH; Su W
Protein Cell; 2020 Oct; 11(10):740-770. PubMed ID: 32780218
[TBL] [Abstract][Full Text] [Related]
35. Dynamic changes in monocytes subsets in COVID-19 patients.
Qin S; Jiang Y; Wei X; Liu X; Guan J; Chen Y; Lu H; Qian J; Wang Z; Lin X
Hum Immunol; 2021 Mar; 82(3):170-176. PubMed ID: 33531264
[TBL] [Abstract][Full Text] [Related]
36. Myelopoiesis of acute inflammation: lessons from TGN1412-induced cytokine storm.
Panoskaltsis N; McCarthy NE; Knight SC
Cancer Immunol Immunother; 2021 Apr; 70(4):1155-1160. PubMed ID: 32862238
[TBL] [Abstract][Full Text] [Related]
37. Nexus between COVID-19 and periodontal disease.
Sukumar K; Tadepalli A
J Int Med Res; 2021 Mar; 49(3):3000605211002695. PubMed ID: 33745336
[TBL] [Abstract][Full Text] [Related]
38. Cytokine Signature Induced by SARS-CoV-2 Spike Protein in a Mouse Model.
Gu T; Zhao S; Jin G; Song M; Zhi Y; Zhao R; Ma F; Zheng Y; Wang K; Liu H; Xin M; Han W; Li X; Dong CD; Liu K; Dong Z
Front Immunol; 2020; 11():621441. PubMed ID: 33584719
[TBL] [Abstract][Full Text] [Related]
39. Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization.
Curtolo A; Oliva A; Volpicelli L; Ceccarelli G; D'Ettorre G; Borrazzo C; Mastroianni CM; Venditti M
Infez Med; 2020 Dec; 28(4):534-538. PubMed ID: 33257627
[TBL] [Abstract][Full Text] [Related]
40. Cytokine storm of a different flavour: The different cytokine signature of SARS-CoV-2, the cause of COVID-19, from the original SARS outbreak.
Griffin DO; Jensen A; Khan M; Chin J; Chin K; Saad J; Parnell R; Awwad C; Patel D
J Glob Antimicrob Resist; 2021 Mar; 24():90-92. PubMed ID: 33242672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
